- Home
- FMY vs LTRN Comparison
FMY vs LTRN Comparison
Compare FMY & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMY
- LTRN
- Stock Information
- Founded
- FMY 2005
- LTRN 2013
- Country
- FMY United States
- LTRN United States
- Employees
- FMY N/A
- LTRN N/A
- Industry
- FMY Finance/Investors Services
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- FMY Finance
- LTRN Health Care
- Exchange
- FMY Nasdaq
- LTRN Nasdaq
- Market Cap
- FMY 51.1M
- LTRN 46.7M
- IPO Year
- FMY N/A
- LTRN 2020
- Fundamental
- Price
- FMY $12.19
- LTRN $3.42
- Analyst Decision
- FMY
- LTRN Buy
- Analyst Count
- FMY 0
- LTRN 2
- Target Price
- FMY N/A
- LTRN $25.00
- AVG Volume (30 Days)
- FMY 10.1K
- LTRN 27.4K
- Earning Date
- FMY 01-01-0001
- LTRN 05-08-2025
- Dividend Yield
- FMY 6.98%
- LTRN N/A
- EPS Growth
- FMY N/A
- LTRN N/A
- EPS
- FMY N/A
- LTRN N/A
- Revenue
- FMY N/A
- LTRN N/A
- Revenue This Year
- FMY N/A
- LTRN N/A
- Revenue Next Year
- FMY N/A
- LTRN N/A
- P/E Ratio
- FMY N/A
- LTRN N/A
- Revenue Growth
- FMY N/A
- LTRN N/A
- 52 Week Low
- FMY $10.71
- LTRN $2.79
- 52 Week High
- FMY $12.17
- LTRN $9.33
- Technical
- Relative Strength Index (RSI)
- FMY 55.97
- LTRN 38.53
- Support Level
- FMY $12.12
- LTRN $3.62
- Resistance Level
- FMY $12.22
- LTRN $3.61
- Average True Range (ATR)
- FMY 0.07
- LTRN 0.25
- MACD
- FMY 0.01
- LTRN -0.02
- Stochastic Oscillator
- FMY 87.05
- LTRN 19.13
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.